The K-shaped gap between Main Street and Wall Street increased last year, as investors looked past a contracting labor pool ...

The year ahead will feature stubborn inflation, an improving job market, and solid economic growth, according to a group of ...

Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. The S&P 500 is supported by robust earnings growth and favorable macro conditions, but ...

Laine Mello, director of marketing at Ecolab Bioprocessing, reflects on how the use of digital technologies expanded in the ...

AXT, Inc. cut its Q4 2025 revenue on China export permit delays; backlog seen Q1-2026 and capacity doubling may lift 2H-2026.

On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his ...

IBM stock surged last year as the tech giant's strategy started to pay off. The AI business is booming, and IBM boosted its ...

VARA rulebooks finalized, RWA tokenization clarified, supervision began. 2026 shifts focus to institutional capital.

During 2025, Aclarion continued to build on its mission to transform the diagnosis of chronic low back pain achieving 69% year-over-year scan volume growth.